Today's briefing covers one AI-governance development from the Federal Register: the National Institutes of Health is seeking public comment on a proposal to establish an Office of the NIH Chief Artificial Intelligence Officer. The office would sit in the Division of Program Coordination, Planning, and Strategic Initiatives within the NIH Office of the Director.
In a notice of proposed reorganization published in the Federal Register on 2026-10-14, the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) in the Office of the Director (OD) of the National Institutes of Health is seeking public comment on a proposal to establish the Office of the NIH Chief Artificial Intelligence Officer (OCAIO) within DPCPSI. The same notice proposes moving the Office of Dietary Supplements (ODS) under the Office of Nutrition Research (ONR), also within DPCPSI. The document is a proposal published for comment; the reorganization is not final.
The notice gives the Chief Artificial Intelligence Officer function at NIH its own named office, placed in a division of the Office of the Director, so AI oversight would be organized at the level of the Director's office. For research institutions, grantees, and vendors whose work touches NIH programs, that office is the unit to watch for agency-level AI policy once the structure is adopted. Organizations with a view on how NIH should organize AI oversight can respond through the comment process the notice opens, and compliance teams tracking federal AI governance should watch for the final reorganization notice to confirm the office's placement before relying on it.
